CliffBio
small molecule

UROBAK

SULFAMETHOXAZOLE

Loss of exclusivity—loss of exclusivity
CompanyShionogi →See this company's full patent-cliff portfolio

Drug detail

Brand nameUROBAK
Active ingredientSULFAMETHOXAZOLE
Strength500MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
Marketing statusDISCN

More from Shionogi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.